cytarabine and u 0126

cytarabine has been researched along with u 0126 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gao, FH; He, W; Sun, Y; Tao, HR; Wang, HW; Xu, MH; Yang, GL; Zhang, C; Zhang, LD; Zhao, JM	1
Aleem, E; Arceci, RJ; Azorsa, DO; Bista, R; Henry, MM; Lee, DW; Patel, AR; Wai, DH	1

Other Studies

2 other study(ies) available for cytarabine and u 0126

Article	Year
Ara-C increases gastric cancer cell invasion by upregulating CD-147-MMP-2/MMP‑9 via the ERK signaling pathway. Oncology reports, 2015, Volume: 33, Issue:4 Topics: Basigin; Butadienes; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cytarabine; Gene Expression Regulation, Neoplastic; Humans; Jurkat Cells; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Nitriles; RNA, Messenger; RNA, Small Interfering; Signal Transduction; Stomach Neoplasms; Up-Regulation	2015
Clinical resistance associated with a novel MAP2K1 mutation in a patient with Langerhans cell histiocytosis. Pediatric blood & cancer, 2018, Volume: 65, Issue:9 Topics: Adolescent; Adrenal Cortex Hormones; Butadienes; Combined Modality Therapy; Cytarabine; Disease Progression; Drug Resistance; Drug Therapy, Combination; Enzyme Activation; Exons; HEK293 Cells; Hematopoietic Stem Cell Transplantation; Histiocytosis, Langerhans-Cell; Humans; Male; MAP Kinase Kinase 1; MAP Kinase Signaling System; Molecular Targeted Therapy; Mutation; Nitriles; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Pyrazoles; Pyridones; Pyrimidinones; Recombinant Fusion Proteins; Sequence Deletion; Thiophenes; Vincristine	2018

Article

Year

Ara-C increases gastric cancer cell invasion by upregulating CD-147-MMP-2/MMP‑9 via the ERK signaling pathway.

Oncology reports, 2015, Volume: 33, Issue:4

Topics: Basigin; Butadienes; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cytarabine; Gene Expression Regulation, Neoplastic; Humans; Jurkat Cells; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Nitriles; RNA, Messenger; RNA, Small Interfering; Signal Transduction; Stomach Neoplasms; Up-Regulation

2015

Clinical resistance associated with a novel MAP2K1 mutation in a patient with Langerhans cell histiocytosis.

Pediatric blood & cancer, 2018, Volume: 65, Issue:9

Topics: Adolescent; Adrenal Cortex Hormones; Butadienes; Combined Modality Therapy; Cytarabine; Disease Progression; Drug Resistance; Drug Therapy, Combination; Enzyme Activation; Exons; HEK293 Cells; Hematopoietic Stem Cell Transplantation; Histiocytosis, Langerhans-Cell; Humans; Male; MAP Kinase Kinase 1; MAP Kinase Signaling System; Molecular Targeted Therapy; Mutation; Nitriles; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Pyrazoles; Pyridones; Pyrimidinones; Recombinant Fusion Proteins; Sequence Deletion; Thiophenes; Vincristine

2018